文献速递介入腹部CTDSAMRUS

经导管CT肝动脉造影与常规CT引导经皮微波消融治疗小肝癌的比较

Transcatheter CT Hepatic Arteriography versus Conventional CT Guidance for Percutaneous Microwave Ablation of Small Hepatocellular Carcinoma Tumors.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

本研究回顾性比较了经导管CT肝动脉造影引导(AA)与常规CT引导(CA)经皮微波消融治疗小于3cm肝细胞癌的安全性和疗效。

要点

  • AA组3个月完全缓解率显著高于CA组(100% vs 79.6%,P=0.0042)。
  • AA组2年无进展生存率更高(95.8% vs 68.5%,log-rank P=0.0099)。
  • 两组总生存率相似(log-rank P=0.583),安全性相当。

局限性

  • 回顾性研究设计。
  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the safety and efficacy of transcatheter CT hepatic arteriography (angio-CT)-guided percutaneous microwave ablation (AA) for small hepatocellular carcinoma tumors and compare its outcomes with those of conventional CT-guided microwave ablation (CA). Materials and Methods The authors performed a retrospective review of patients with hepatocellular carcinoma tumors less than 3 cm in size treated with AA and CA from June 2019 to August 2024 at a single institution. Hepatic arteriography was performed after transarterial catheterization in an angio-CT hybrid suite. CA was performed with or without US. The authors evaluated the target-lesion radiologic response according to modified Response Evaluation Criteria in Solid Tumors criteria at follow-up contrast-enhanced CT or MRI. Target-lesion progression-free survival (PFS) and overall survival were calculated using the Kaplan-Meier method. Cox regression hazard models were used to identify variables associated with PFS. Adverse events were retrospectively reviewed. Results A total of 70 patients and 85 tumors were included in this study (mean age, 63.2 years ± 9.5 [SD]; 49 male patients). Thirty-six tumors (27 patients) were treated with AA. Forty-nine tumors (43 patients) were treated with CA. The 3-month complete response rate (100% vs 79.6%; P = .0042) and the 2-year PFS rate (95.8% vs 68.5%; log-rank P = .0099) were higher for the AA group than the CA group. Overall survival was similar between the groups (log-rank P = .583). In the multivariable analysis, AA but not CA was independently associated with increased PFS (P = .009). One patient from the CA group developed hemorrhagic shock after ablation. No other severe adverse events or grade 3 or above hepatic toxicities occurred. Conclusion For hepatocellular carcinoma tumors less than 3 cm in size, AA resulted in higher initial response and PFS rates than CA with comparable safety profile. Keywords: Angio-CT, Hepatocellular Carcinoma, Microwave Ablation Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Yu Q, Ahmed Z, Lim W, et al. Transcatheter CT Hepatic Arteriography versus Conventional CT Guidance for Percutaneous Microwave Ablation of Small Hepatocellular Carcinoma Tumors. Radiol Imaging Cancer. 2026. PMID: 42171489. doi:10.1148/rycan.250106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。